Epitopea Alternatives & Competitors
12 companies similar to Epitopea — Exploiting a new class of tumour specific antigens for cancer therapy
Companies similar to Epitopea
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
Mosaic TX
Resolving cancer's complexity through the power of targeted drug combinations
United Kingdom
Arcellx
Arcellx is a clinical-stage biotechnology company based in Redwood City, California
Redwood City, United Stat...
Enara Bio
Advancing cancer immunotherapy by targeting the unconventional
Oxford, United Kingdom
Track all Epitopea competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
TREOS THERAPEUTICS
Changing the paradigm of active cancer immunotherapy development
London, United Kingdom
Breakpoint Therapeutics
Modulating DNA damage responses to cure cancer
Hamburg, Germany
Imvax, Inc.
Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-deriv...
Philadelphia, United Stat...
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
FogPharma
Until everything is druggable.
Cambridge, United States
IconOVir Bio
Pushing the envelope: Our mission is to cure cancer and restore life to every patient ever...
San Diego, United States
ImCheck Therapeutics
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic
Marseille, France
Neogene Therapeutics
Pushing the frontier by pioneering next-generation engineered T cell receptor therapies fo...
Amsterdam, The Netherland...
About Epitopea
Epitopea, founded in 2021, is a promising player in the Biotechnology, Health and Wellness, and Life Sciences sectors, headquartered in Canada. The company is pioneering cancer therapy by exploiting a novel class of tumor-specific antigens. With the slogan, "Exploiting a new class of tumour specific antigens for cancer...
Development of off-the-shelf RNA-based cancer immunotherapies, Identification of shared aberrantly expressed tumor-specific antigens, Creation and optimization of Cryptomap platform
Cancer patients, Healthcare providers, Cancer research institutions
Cancer Therapy, Tumour-specific Antigen, Therapeutics Development, Oncology, Immunotherapy, Clinical Trials, Biomarker, Cancer Treatment, Antigen Targeting, Precision Medicine
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Epitopea and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Epitopea on 11 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
